Viveve (NSDQ:VIVE) said last week that it is looking to raise up to $6.76 million in a common stock offering, according to a regulatory filing. The stock is being offered at $0.13 per share, which was the last reported sale price of its common stock on August 15, 2019. The actual number of shares issued […]
Willow adds $23m for cordless, hands-free breast pump
Willow yesterday reported raising nearly $23 million for the cordless, hands-free breast pump it’s developing. The Mountain View, Calif.-based company, which gestated at California’s ExploraMed incubator, said in a regulatory filing that seven unnamed investors participated in the equity round, which brought in a total of $22.7 million. The latest raise takes the total funding […]
BD sues Stryker over PureWick catheter patents
Becton Dickinson (NYSE:BDX) this week levied a lawsuit against Stryker (NYSE:SYK), alleging infringement of patents covering its PureWick female external catheter. The lawsuit, filed August 12 in the U.S. District Court for Delaware, accused Stryker’s Sage Products subsidiary of violating two patents covering the PureWick device with Sage’s competing PrimaFit device, which Stryker acquired along with […]
Hologic beats The Street on Q3 earnings
Hologic (NSDQ:HOLX) reported third-quarter earnings this evening that beat the consensus forecast on Wall Street, raising its full-year guidance. The Marlborough, Mass.–based women’s health medtech company reported profits of $93.9 million, or $0.35 per share, on sales of $852.4 million for the three months ended June 29, for a bottom-line decrease of 16.8% and sales growth […]
Minerva Surgical claims win against Hologic
Minerva Surgical today claimed a win in its patent infringement war with Hologic (NSDQ:HOLX) over endometrial ablation technology, after a federal appeals court upheld a ruling that invalidates one of the Hologic patents in question. The convoluted battle involves the NovaSure device Hologic acquired with the 2007 buyout of Cytyc (which had acquired NovaSure developer Novacept […]
UPDATE: FDA asks Allergan to recall textured breast implants
UPDATED July 24, 2019, with new FDA statement. The FDA said today that it asked Allergan (NYSE: AGN) to recall its Biocell breast implants after concluding that they are six times as likely as other textured breast implants to cause an uncommon form of lymphoma. The federal safety watchdog said that nearly 84% of the 573 […]
AirXpanders abruptly pulls the plug
AirXpanders (ASX:AXP) abruptly pulled the plug yesterday, saying it plans to lay off nearly all its employees and file for Chapter 7 bankruptcy by the end of the month. The Palo Alto, Calif.–based company makes the AeroForm device for post-mastectomy breast reconstruction. It’s designed to expand and stretch the skin and underlying muscle prior to […]
First state AG suit over pelvic mesh heads to trial
The first lawsuit filed by a state attorney general, California’s Xavier Becerra, over pelvic mesh products went to trial yesterday in San Diego. The lawsuit alleges that Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon concealed the potential risks of pelvic mesh from the public and physicians. It’s the first of several lawsuits brought by state AGs […]
AirXpanders wins FDA clearance for smooth AeroForm
AirXpanders said today that it has received FDA clearance to market a smooth shell version of its AeroForm Tissue Expander. The Palo Alto, Calif.–based company makes the AeroForm device for post-mastectomy breast reconstruction. It is designed to expand and stretch the skin and underlying muscle prior to a permanent breast implant using small amounts of […]
iCad’s AI-assisted mammography tech wins CE Mark
iCad (NSDQ:ICAD) has won the CE Mark for its advanced artificial intelligence technology and workflow solution, ProFound AI for 2D mammography. The Nashua, N.H.-based cancer detection and radiation therapy devices maker developed the technology to boost breast cancer detection by identifying soft-tissue densities and calcifications. ProFound AI for 2D mammography is the latest addition to […]
AblaCare raises $11.3 million, appoints CEO
Infertility treatment company AblaCare said today that it has raised €10 million ($11.3 million) in Series A financing from Sofinnova Partners and the appointment of medtech veteran Jodie Fam as CEO. The Paris-based company’s minimally invasive ablation technology was designed to treat polycystic ovarian syndrome (PCOS) as an alternative to a surgical method known as […]
- 1
- 2
- 3
- …
- 58
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube